机译:Novel emerging therapies in atherosclerosis targeting lipid metabolism
Imperial Ctr Cardiovasc Dis Prevent, London, England;
Westchester Med Ctr, Dept Cardiol, New York, NY USA;
Union Mem Hosp, MedStar Heart & Vasc Inst, Johnston Profess Bldg,Suite 500,3333 N Calvert StUniv Connecticut, Dept Internal Med, Hartford, CT 06112 USAJohns Hopkins Univ, Sch Med, Dept Internal Med, Baltimore, MD USARajendra Inst Med Sci, Dept Med, Ranchi, Bihar, IndiaIcahn Sch Med Mt Sinai, Mt Sinai St Lukes Roosevelt Hosp, Dept Internal Med, New York, NY 10029 USACleveland Clin, Dept Internal Med, Cleveland, OH 44106 USAUniv Queensland, Sch Med, John Ochsner Heart & Vasc Inst, Ochsner Clin Sch, New Orleans, LA USABaylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Sect Cardiol, Houston, TX 77030 USA;
Atherosclerosis; bempedoic acid; inclisiran; pemafibrate; PCSK9 inhibitors; IMPROVE-IT; FOURIER; ODYSSEY; ORION-10; CLEAR harmony; lomitapide; evinacumab; pemfibrate; REDUCE-IT; EVAPORATE;